Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 325 | 1,064 | 1,513 | 1,738 | 5,343 |
| Cost of Goods | 0 | N/A | N/A | 237 | 410 |
| Gross Profit | 325 | 1,064 | 1,513 | 1,501 | 4,933 |
| Operating Expenses | 37,708 | 35,424 | 31,784 | 22,854 | 9,659 |
| Operating Income | -37,383 | -34,360 | -30,271 | -21,116 | -4,316 |
| Interest Expense | 786 | 1,683 | 1,606 | 1,728 | 2,333 |
| Other Income | -2,177 | 1,259 | 3,287 | 3,267 | 330 |
| Pre-tax Income | -40,346 | -34,784 | -28,590 | -19,577 | -6,319 |
| Net Income Continuous | -40,346 | -34,784 | -28,590 | -19,577 | -6,319 |
| Net Income Discontinuous | N/A | 273 | -6,175 | -3,491 | -4,855 |
| Net Income | $-40,346 | $-34,511 | $-34,765 | $-23,068 | $-11,174 |
| EPS Basic Total Ops | -9.40 | -10.20 | -11.40 | -7.80 | -5.20 |
| EPS Basic Continuous Ops | -9.43 | -10.20 | -9.40 | -6.60 | -3.00 |
| EPS Basic Discontinuous Ops | N/A | 0.08 | -2.00 | -1.20 | -2.20 |
| EPS Diluted Total Ops | -9.40 | -10.20 | -11.40 | -7.80 | -5.20 |
| EPS Diluted Continuous Ops | -9.43 | -10.20 | -9.40 | -6.60 | -3.00 |
| EPS Diluted Discontinuous Ops | N/A | 0.08 | -2.00 | -1.20 | -2.20 |
| EBITDA(a) | $-35,820 | $-32,981 | $-31,277 | $-20,745 | $-2,527 |